HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cardillo, G. Articles by Martelli, M. Search for Related Content PubMed PubMed Citation Articles by Cardillo, G. Articles by Martelli, M. Related Collections Pleura

Eur J Cardiothorac Surg 2002;21:302-306
© 2002 Elsevier Science NL

Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions

Department of Thoracic Surgery, Carlo Forlanini Hospital, Via Portuense 332, 00149, Rome, Italy

Received 13 September 2001; received in revised form 22 November 2001; accepted 27 November 2001.

* Corresponding author. Tel.: +39-06-55180680; fax: +39-06-6638734
e-mail: gcardillo{at}scamilloforlanini.rm.it

Objective: Recurrent pleural effusion is a common condition and often presents a challenge for treatment. The aim of this report is to evaluate the long-term follow-up of thoracoscopic management of malignant recurrent pleural effusions. Methods: From July 1st, 1992 to February 28th, 2001, out of 2311 VATS procedures performed at our Institution, 690 patients (29.85%) underwent videothoracoscopy (VATS) for recurrent pleural effusion. Of these 611 (88.55%) were treated for a malignant pleural effusion. There were 374 male and 237 female, with a mean age of 61.2 years. In all patients VATS was performed under general anaesthesia. The pleural affusion was carefully aspirated; fibrinous adhesions were taken down while dense fibrous adhesions were selectively divided; some limited decortications were also performed. Multiple pleural biopsies were always performed. Pleurodesis was performed with 5 g of sterile purified talc insufflated through a talc atomizer. One chest tube was left in situ for 3–5 days. Results: Operative mortality was 0.81% (five cases). Postoperative complications occurred in 19 cases (3.1%). Specific histologic diagnosis was obtained in all patients. Follow-up was available for 602 patients (98.5%). After a median follow-up of 64 months (range 5–105 months), talc pleurodesis was successful in controlling recurrence of effusion in 92.7% (558 out of 602) of patients. The success rate did not show any statistically significant difference between patients who underwent postoperative adjuvant therapy and patients who did not. In two patients with failure of talc pleurodesis a redo-VATS was performed. Conclusions: VATS represents the method of choice for both diagnosis and treatment of malignant recurrent pleural effusions. Talc poudrage is safe and effective in obtaining pleurodesis.

Key Words: Video-assisted thoracic surgery • Pleural effusion • Recurrent pleural effusion • Pleurodesis • Treatment

This article has been cited by other articles:

				R. A Qureshi, S. L Collinson, R. J Powell, P. O Froeschle, and R. G Berrisford Management of Malignant Pleural Effusion Associated with Trapped Lung Syndrome Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 120 - 123. [Abstract] [Full Text] [PDF]

				M. Noppen Who's (still) afraid of talc? Eur. Respir. J., April 1, 2007; 29(4): 619 - 621. [Full Text] [PDF]

				T. J. Kuzniar, M. G. Blum, K. Kasibowska-Kuzniar, and G. M. Mutlu Predictors of Acute Lung Injury and Severe Hypoxemia in Patients Undergoing Operative Talc Pleurodesis Ann. Thorac. Surg., December 1, 2006; 82(6): 1976 - 1981. [Abstract] [Full Text] [PDF]

				F. Rodriguez-Panadero, J. P. Janssen, and P. Astoul Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur. Respir. J., August 1, 2006; 28(2): 409 - 422. [Full Text] [PDF]

				T. Laisaar, V. Palmiste, T. Vooder, and T. Umbleja Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 307 - 310. [Abstract] [Full Text] [PDF]

				A. L. Akopov, V. I. Egorov, V. V. Varlamov, Y. N. Levashev, and D. Y. Artioukh Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 750 - 753. [Abstract] [Full Text] [PDF]

				S. Kolschmann, A. Ballin, and A. Gillissen Clinical Efficacy and Safety of Thoracoscopic Talc Pleurodesis in Malignant Pleural Effusions Chest, September 1, 2005; 128(3): 1431 - 1435. [Abstract] [Full Text] [PDF]

				R. W. Light Talc for Pleurodesis? Chest, November 1, 2002; 122(5): 1506 - 1508. [Full Text] [PDF]